Cover

Loading…
Abstract Nipah virus (NiV) is a member of the genus Henipavirus (family Paramyxoviridae) that causes severe and often lethal respiratory illness and encephalitis in humans with high mortality rates (up to 92%). NiV can cause Acute Lung Injury (ALI) in humans, and human-to-human transmission has been observed in recent outbreaks of NiV. While the exact route of transmission to humans is not known, we have previously shown that NiV can efficiently infect human respiratory epithelial cells. The molecular mechanisms of NiV-associated ALI in the human respiratory tract are unknown. Thus, there is an urgent need for models of henipavirus infection of the human respiratory tract to study the pathogenesis and understand the host responses. Here, we describe a novel human lung xenograft model in mice to study the pathogenesis of NiV. Following transplantation, human fetal lung xenografts rapidly graft and develop mature structures of adult lungs including cartilage, vascular vessels, ciliated pseudostratified columnar epithelium, and primitive "air" spaces filled with mucus and lined by cuboidal to flat epithelium. Following infection, NiV grows to high titers (10(7) TCID50/gram lung tissue) as early as 3 days post infection (pi). NiV targets both the endothelium as well as respiratory epithelium in the human lung tissues, and results in syncytia formation. NiV infection in the human lung results in the production of several cytokines and chemokines including IL-6, IP-10, eotaxin, G-CSF and GM-CSF on days 5 and 7 pi. In conclusion, this study demonstrates that NiV can replicate to high titers in a novel in vivo model of the human respiratory tract, resulting in a robust inflammatory response, which is known to be associated with ALI. This model will facilitate progress in the fundamental understanding of henipavirus pathogenesis and virus-host interactions; it will also provide biologically relevant models for other respiratory viruses.
AbstractList Nipah virus (NiV) is a member of the genus Henipavirus (family Paramyxoviridae) that causes severe and often lethal respiratory illness and encephalitis in humans with high mortality rates (up to 92%). NiV can cause Acute Lung Injury (ALI) in humans, and human-to-human transmission has been observed in recent outbreaks of NiV. While the exact route of transmission to humans is not known, we have previously shown that NiV can efficiently infect human respiratory epithelial cells. The molecular mechanisms of NiV-associated ALI in the human respiratory tract are unknown. Thus, there is an urgent need for models of henipavirus infection of the human respiratory tract to study the pathogenesis and understand the host responses. Here, we describe a novel human lung xenograft model in mice to study the pathogenesis of NiV. Following transplantation, human fetal lung xenografts rapidly graft and develop mature structures of adult lungs including cartilage, vascular vessels, ciliated pseudostratified columnar epithelium, and primitive "air" spaces filled with mucus and lined by cuboidal to flat epithelium. Following infection, NiV grows to high titers (10(7) TCID50/gram lung tissue) as early as 3 days post infection (pi). NiV targets both the endothelium as well as respiratory epithelium in the human lung tissues, and results in syncytia formation. NiV infection in the human lung results in the production of several cytokines and chemokines including IL-6, IP-10, eotaxin, G-CSF and GM-CSF on days 5 and 7 pi. In conclusion, this study demonstrates that NiV can replicate to high titers in a novel in vivo model of the human respiratory tract, resulting in a robust inflammatory response, which is known to be associated with ALI. This model will facilitate progress in the fundamental understanding of henipavirus pathogenesis and virus-host interactions; it will also provide biologically relevant models for other respiratory viruses.Nipah virus (NiV) is a member of the genus Henipavirus (family Paramyxoviridae) that causes severe and often lethal respiratory illness and encephalitis in humans with high mortality rates (up to 92%). NiV can cause Acute Lung Injury (ALI) in humans, and human-to-human transmission has been observed in recent outbreaks of NiV. While the exact route of transmission to humans is not known, we have previously shown that NiV can efficiently infect human respiratory epithelial cells. The molecular mechanisms of NiV-associated ALI in the human respiratory tract are unknown. Thus, there is an urgent need for models of henipavirus infection of the human respiratory tract to study the pathogenesis and understand the host responses. Here, we describe a novel human lung xenograft model in mice to study the pathogenesis of NiV. Following transplantation, human fetal lung xenografts rapidly graft and develop mature structures of adult lungs including cartilage, vascular vessels, ciliated pseudostratified columnar epithelium, and primitive "air" spaces filled with mucus and lined by cuboidal to flat epithelium. Following infection, NiV grows to high titers (10(7) TCID50/gram lung tissue) as early as 3 days post infection (pi). NiV targets both the endothelium as well as respiratory epithelium in the human lung tissues, and results in syncytia formation. NiV infection in the human lung results in the production of several cytokines and chemokines including IL-6, IP-10, eotaxin, G-CSF and GM-CSF on days 5 and 7 pi. In conclusion, this study demonstrates that NiV can replicate to high titers in a novel in vivo model of the human respiratory tract, resulting in a robust inflammatory response, which is known to be associated with ALI. This model will facilitate progress in the fundamental understanding of henipavirus pathogenesis and virus-host interactions; it will also provide biologically relevant models for other respiratory viruses.
  Nipah virus (NiV) is a member of the genus Henipavirus (family Paramyxoviridae) that causes severe and often lethal respiratory illness and encephalitis in humans with high mortality rates (up to 92%). NiV can cause Acute Lung Injury (ALI) in humans, and human-to-human transmission has been observed in recent outbreaks of NiV. While the exact route of transmission to humans is not known, we have previously shown that NiV can efficiently infect human respiratory epithelial cells. The molecular mechanisms of NiV-associated ALI in the human respiratory tract are unknown. Thus, there is an urgent need for models of henipavirus infection of the human respiratory tract to study the pathogenesis and understand the host responses. Here, we describe a novel human lung xenograft model in mice to study the pathogenesis of NiV. Following transplantation, human fetal lung xenografts rapidly graft and develop mature structures of adult lungs including cartilage, vascular vessels, ciliated pseudostratified columnar epithelium, and primitive "air" spaces filled with mucus and lined by cuboidal to flat epithelium. Following infection, NiV grows to high titers (107 TCID50/gram lung tissue) as early as 3 days post infection (pi). NiV targets both the endothelium as well as respiratory epithelium in the human lung tissues, and results in syncytia formation. NiV infection in the human lung results in the production of several cytokines and chemokines including IL-6, IP-10, eotaxin, G-CSF and GM-CSF on days 5 and 7 pi. In conclusion, this study demonstrates that NiV can replicate to high titers in a novel in vivo model of the human respiratory tract, resulting in a robust inflammatory response, which is known to be associated with ALI. This model will facilitate progress in the fundamental understanding of henipavirus pathogenesis and virus-host interactions; it will also provide biologically relevant models for other respiratory viruses.
Nipah virus (NiV) is a member of the genus Henipavirus (family Paramyxoviridae) that causes severe and often lethal respiratory illness and encephalitis in humans with high mortality rates (up to 92%). NiV can cause Acute Lung Injury (ALI) in humans, and human-to-human transmission has been observed in recent outbreaks of NiV. While the exact route of transmission to humans is not known, we have previously shown that NiV can efficiently infect human respiratory epithelial cells. The molecular mechanisms of NiV-associated ALI in the human respiratory tract are unknown. Thus, there is an urgent need for models of henipavirus infection of the human respiratory tract to study the pathogenesis and understand the host responses. Here, we describe a novel human lung xenograft model in mice to study the pathogenesis of NiV. Following transplantation, human fetal lung xenografts rapidly graft and develop mature structures of adult lungs including cartilage, vascular vessels, ciliated pseudostratified columnar epithelium, and primitive "air" spaces filled with mucus and lined by cuboidal to flat epithelium. Following infection, NiV grows to high titers (10(7) TCID50/gram lung tissue) as early as 3 days post infection (pi). NiV targets both the endothelium as well as respiratory epithelium in the human lung tissues, and results in syncytia formation. NiV infection in the human lung results in the production of several cytokines and chemokines including IL-6, IP-10, eotaxin, G-CSF and GM-CSF on days 5 and 7 pi. In conclusion, this study demonstrates that NiV can replicate to high titers in a novel in vivo model of the human respiratory tract, resulting in a robust inflammatory response, which is known to be associated with ALI. This model will facilitate progress in the fundamental understanding of henipavirus pathogenesis and virus-host interactions; it will also provide biologically relevant models for other respiratory viruses.
Nipah virus (NiV) is a member of the genus Henipavirus (family Paramyxoviridae) that causes severe and often lethal respiratory illness and encephalitis in humans with high mortality rates (up to 92%). NiV can cause Acute Lung Injury (ALI) in humans, and human-to-human transmission has been observed in recent outbreaks of NiV. While the exact route of transmission to humans is not known, we have previously shown that NiV can efficiently infect human respiratory epithelial cells. The molecular mechanisms of NiV-associated ALI in the human respiratory tract are unknown. Thus, there is an urgent need for models of henipavirus infection of the human respiratory tract to study the pathogenesis and understand the host responses. Here, we describe a novel human lung xenograft model in mice to study the pathogenesis of NiV. Following transplantation, human fetal lung xenografts rapidly graft and develop mature structures of adult lungs including cartilage, vascular vessels, ciliated pseudostratified columnar epithelium, and primitive "air" spaces filled with mucus and lined by cuboidal to flat epithelium. Following infection, NiV grows to high titers ([10.sup.7] [TCID.sub.50]/gram lung tissue) as early as 3 days post infection (pi). NiV targets both the endothelium as well as respiratory epithelium in the human lung tissues, and results in syncytia formation. NiV infection in the human lung results in the production of several cytokines and chemokines including IL-6, IP-10, eotaxin, G-CSF and GM-CSF on days 5 and 7 pi. In conclusion, this study demonstrates that NiV can replicate to high titers in a novel in vivo model of the human respiratory tract, resulting in a robust inflammatory response, which is known to be associated with ALI. This model will facilitate progress in the fundamental understanding of henipavirus pathogenesis and virus-host interactions; it will also provide biologically relevant models for other respiratory viruses.
Nipah virus (NiV) is a member of the genus Henipavirus (family Paramyxoviridae ) that causes severe and often lethal respiratory illness and encephalitis in humans with high mortality rates (up to 92%). NiV can cause Acute Lung Injury (ALI) in humans, and human-to-human transmission has been observed in recent outbreaks of NiV. While the exact route of transmission to humans is not known, we have previously shown that NiV can efficiently infect human respiratory epithelial cells. The molecular mechanisms of NiV-associated ALI in the human respiratory tract are unknown. Thus, there is an urgent need for models of henipavirus infection of the human respiratory tract to study the pathogenesis and understand the host responses. Here, we describe a novel human lung xenograft model in mice to study the pathogenesis of NiV. Following transplantation, human fetal lung xenografts rapidly graft and develop mature structures of adult lungs including cartilage, vascular vessels, ciliated pseudostratified columnar epithelium, and primitive “air” spaces filled with mucus and lined by cuboidal to flat epithelium. Following infection, NiV grows to high titers (10 7 TCID 50 /gram lung tissue) as early as 3 days post infection (pi). NiV targets both the endothelium as well as respiratory epithelium in the human lung tissues, and results in syncytia formation. NiV infection in the human lung results in the production of several cytokines and chemokines including IL-6, IP-10, eotaxin, G-CSF and GM-CSF on days 5 and 7 pi. In conclusion, this study demonstrates that NiV can replicate to high titers in a novel in vivo model of the human respiratory tract, resulting in a robust inflammatory response, which is known to be associated with ALI. This model will facilitate progress in the fundamental understanding of henipavirus pathogenesis and virus-host interactions; it will also provide biologically relevant models for other respiratory viruses. Nipah virus (NiV) is a highly pathogenic zoonotic virus that causes fatal disease in humans and a variety of other mammalian hosts including pigs. Given the lack of effective therapeutics and vaccines, this virus is considered a public health and agricultural concern, and listed as category C priority pathogen for biodefense research by the National Institute of Allergy and Infectious Diseases. Both animal-to-human and human-to-human transmission has been observed. Studies on the molecular mechanisms of NiV-mediated pathogenesis have been hampered by the lack of biologically relevant in vivo models for studying the initial host responses to NiV infection in the human lung. We show here a new small animal model in which we transplant human lung tissue for studying the pathogenesis of NiV. We showed that NiV can replicate to high levels in the human lung. NiV causes extensive damage to the lung tissue and induces important regulators of the inflammatory response. This study is the first to use a human lung transplant for studying infectious diseases, a powerful model for studying the pathogenesis of NiV infection, and will open up new possibilities for studying virus-host interactions.
Audience Academic
Author Valbuena, Gustavo
Halliday, Hailey
Rockx, Barry
Borisevich, Viktoriya
Goez, Yenny
AuthorAffiliation 1 Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America
Johns Hopkins University, United States of America
2 Institute of Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, United States of America
3 Department Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America
AuthorAffiliation_xml – name: Johns Hopkins University, United States of America
– name: 2 Institute of Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, United States of America
– name: 1 Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America
– name: 3 Department Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America
Author_xml – sequence: 1
  givenname: Gustavo
  surname: Valbuena
  fullname: Valbuena, Gustavo
– sequence: 2
  givenname: Hailey
  surname: Halliday
  fullname: Halliday, Hailey
– sequence: 3
  givenname: Viktoriya
  surname: Borisevich
  fullname: Borisevich, Viktoriya
– sequence: 4
  givenname: Yenny
  surname: Goez
  fullname: Goez, Yenny
– sequence: 5
  givenname: Barry
  surname: Rockx
  fullname: Rockx, Barry
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24699832$$D View this record in MEDLINE/PubMed
BookMark eNqVkmuL1DAUhousuBf9B6IFv-iHGXNpk8kKwrCoOzCu4A2_hdP0pJulk4xJK_rvzTgzsiMiSKBJ0-d9c3L6nhZHPngsioeUTCmX9PlNGKOHfrpewzClhFRE8DvFCa1rPpFcVke31sfFaUo3maGcinvFMauEUjPOTooX8_JyXIEvl6Pvyi_oQxfBDuXbMCbMzxb7Mtjyyq3huvzs4pjKhbdoBhf8_eKuhT7hg918Vnx6_erjxeVk-e7N4mK-nBjB-TChrWWkaVGCNE1dG44SKTMtb6jlVqqaA7ayYWbWAkWLRFHCGmiYRARUjJ8Vj7e-6z4kvbt30rRmNVOSCJKJxZZoA9zodXQriD90AKd_bYTYaYiDMz1qEEAZSJRGmQo4mfGaVm0zEwLyqxTZ6-XutLFZYWvQDxH6A9PDL95d6y5801zJaibrbPB0ZxDD1xHToFcuGex78Ji7muumnFSqYjKjT7ZoB7k0523IjmaD6zkXUiqlxOb-079QebS4cianwrq8fyB4diDIzIDfhw7GlPTiw_v_YK8O2Ue3W_O7J_s4ZeB8C5gYUopotXEDbLKSK3a9pkRvsrv_h3qTXb3LbhZXf4j3_v-U_QSqq_M-
CitedBy_id crossref_primary_10_4049_jimmunol_2100122
crossref_primary_10_1371_journal_pntd_0006343
crossref_primary_10_2217_fvl_2016_0027
crossref_primary_10_1038_s41392_024_01917_x
crossref_primary_10_1093_infdis_jiy357
crossref_primary_10_1186_s12985_023_01971_x
crossref_primary_10_3390_v13091755
crossref_primary_10_1016_j_antiviral_2022_105314
crossref_primary_10_1128_JVI_01537_21
crossref_primary_10_1016_j_nano_2019_03_004
crossref_primary_10_1016_j_micpath_2021_104908
crossref_primary_10_1146_annurev_pathol_052016_100332
crossref_primary_10_52711_0974_360X_2023_00592
crossref_primary_10_3390_ijms24097734
crossref_primary_10_1002_bdrb_21131
crossref_primary_10_1016_j_clinthera_2019_08_010
crossref_primary_10_1126_sciadv_abe1235
crossref_primary_10_1371_journal_ppat_1012875
crossref_primary_10_1128_JVI_00275_17
crossref_primary_10_3390_microorganisms10061162
crossref_primary_10_1007_s00005_018_0506_x
crossref_primary_10_1038_ncomms8483
crossref_primary_10_3390_v15101980
crossref_primary_10_2174_1871526522666220117120859
crossref_primary_10_1128_cmr_00128_23
crossref_primary_10_1172_jci_insight_126070
crossref_primary_10_1002_path_4444
crossref_primary_10_1186_s13287_022_02787_2
crossref_primary_10_1016_j_micinf_2019_02_002
crossref_primary_10_3390_v14050936
crossref_primary_10_1099_jgv_0_000243
crossref_primary_10_1099_jgv_0_000441
crossref_primary_10_1186_s12977_021_00557_1
Cites_doi 10.3201/eid1012.040701
10.1371/journal.pntd.0002024
10.1016/S0002-9440(10)63569-9
10.1371/journal.pone.0063331
10.1128/JVI.00473-11
10.1371/journal.pone.0040308
10.1016/j.ajpath.2013.06.023
10.1371/journal.ppat.1000642
10.1038/nbt1210-1248
10.3201/eid1307.061128
10.1136/thx.2005.040204
10.3201/eid1812.120875
10.1016/S0002-9440(10)64493-8
10.1093/infdis/jis653
10.1086/529147
10.1002/smll.200801572
10.1126/scitranslmed.3004241
10.1046/j.1432-0436.1995.5850361.x
10.1016/j.virol.2010.05.005
10.1016/S0140-6736(99)04299-3
10.1073/pnas.93.7.3126
10.1016/j.antiviral.2012.05.008
10.1016/j.virusres.2007.02.014
10.1016/S0016-5085(03)00902-8
10.3855/jidc.3648
10.1378/chest.107.4.1062
10.1128/JVI.00549-11
10.1371/journal.pone.0010690
10.4049/jimmunol.154.1.180
10.1160/TH09-05-0310
10.1186/1743-422X-5-142
10.1111/j.1600-6143.2012.04018.x
10.1073/pnas.0813234106
10.1128/JVI.02576-12
10.1378/chest.111.5.1306
10.1128/JVI.00127-09
10.1016/S0140-6736(99)04379-2
ContentType Journal Article
Copyright COPYRIGHT 2014 Public Library of Science
2014 Valbuena et al 2014 Valbuena et al
2014 Valbuena et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Valbuena G, Halliday H, Borisevich V, Goez Y, Rockx B (2014) A Human Lung Xenograft Mouse Model of Nipah Virus Infection. PLoS Pathog 10(4): e1004063. doi:10.1371/journal.ppat.1004063
Copyright_xml – notice: COPYRIGHT 2014 Public Library of Science
– notice: 2014 Valbuena et al 2014 Valbuena et al
– notice: 2014 Valbuena et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Valbuena G, Halliday H, Borisevich V, Goez Y, Rockx B (2014) A Human Lung Xenograft Mouse Model of Nipah Virus Infection. PLoS Pathog 10(4): e1004063. doi:10.1371/journal.ppat.1004063
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISN
ISR
7X8
5PM
DOA
DOI 10.1371/journal.ppat.1004063
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Canada
Gale In Context: Science
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic




MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Nipah Virus Infection in Human Lung
EISSN 1553-7374
ExternalDocumentID 1525297060
oai_doaj_org_article_a6a12a7e7c9c4a3083514db866a4a376
PMC3974875
A367799962
24699832
10_1371_journal_ppat_1004063
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations Bangladesh
GeographicLocations_xml – name: Bangladesh
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: U54 AI057156
GroupedDBID ---
123
29O
2WC
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
B0M
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAP
EAS
EBD
EMK
EMOBN
ESX
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
ISN
ISR
ITC
KQ8
LK8
M1P
M48
M7P
MM.
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
QF4
QN7
RNS
RPM
SV3
TR2
TUS
UKHRP
WOW
~8M
3V.
CGR
CUY
CVF
ECM
EIF
H13
IPNFZ
M~E
NPM
PV9
RIG
RZL
WOQ
PMFND
7X8
PJZUB
PPXIY
PQGLB
5PM
PUEGO
-
AAPBV
ABPTK
ADACO
BBAFP
PQEST
PQUKI
PRINS
ID FETCH-LOGICAL-c633t-1df20bde7a7cb55c3e7e12cd3b1f3f7953aed7b2c8da1efe09102bab27eeae923
IEDL.DBID M48
ISSN 1553-7374
1553-7366
IngestDate Fri Nov 26 17:14:09 EST 2021
Wed Aug 27 01:07:39 EDT 2025
Thu Aug 21 18:24:27 EDT 2025
Thu Aug 07 13:51:08 EDT 2025
Tue Jun 17 20:48:42 EDT 2025
Tue Jun 10 20:42:39 EDT 2025
Fri Jun 27 04:12:41 EDT 2025
Fri Jun 27 03:57:26 EDT 2025
Wed Feb 19 02:29:40 EST 2025
Tue Jul 01 01:10:15 EDT 2025
Thu Apr 24 22:50:23 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c633t-1df20bde7a7cb55c3e7e12cd3b1f3f7953aed7b2c8da1efe09102bab27eeae923
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
The authors have declared that no competing interests exist.
Conceived and designed the experiments: GV BR. Performed the experiments: GV HH VB YG BR. Analyzed the data: GV BR. Wrote the paper: GV BR.
OpenAccessLink https://doaj.org/article/a6a12a7e7c9c4a3083514db866a4a376
PMID 24699832
PQID 1513049427
PQPubID 23479
ParticipantIDs plos_journals_1525297060
doaj_primary_oai_doaj_org_article_a6a12a7e7c9c4a3083514db866a4a376
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3974875
proquest_miscellaneous_1513049427
gale_infotracmisc_A367799962
gale_infotracacademiconefile_A367799962
gale_incontextgauss_ISR_A367799962
gale_incontextgauss_ISN_A367799962
pubmed_primary_24699832
crossref_citationtrail_10_1371_journal_ppat_1004063
crossref_primary_10_1371_journal_ppat_1004063
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-04-01
PublicationDateYYYYMMDD 2014-04-01
PublicationDate_xml – month: 04
  year: 2014
  text: 2014-04-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco, USA
PublicationTitle PLoS pathogens
PublicationTitleAlternate PLoS Pathog
PublicationYear 2014
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References S Erbar (ref10) 2008; 5
AS Headley (ref37) 1997; 111
S Abele-Ohl (ref22) 2012; 12
BA Clayton (ref25) 2012; 18
J Dups (ref29) 2012; 7
R Gao (ref31) 2013; 183
GU Meduri (ref36) 1995; 107
MK Lo (ref9) 2010; 404
VP Hsu (ref4) 2004; 10
M Uhlen (ref23) 2010; 28
MJ Hossain (ref6) 2008; 46
B Rockx (ref13) 2011; 85
A Maisner (ref11) 2009; 102
KN Bossart (ref14) 2012; 4
KT Wong (ref17) 2003; 163
O Escaffre (ref12) 2013; 87
TR Kollmann (ref21) 1996; 93
TW Geisbert (ref16) 2010; 5
ES Gurley (ref5) 2007; 13
KT Wong (ref8) 2002; 161
C Mathieu (ref27) 2011; 85
KN Bossart (ref15) 2009; 5
TC Savidge (ref20) 2003; 125
JE Podesta (ref18) 2009; 5
KB Chua (ref2) 1999; 354
B Rockx (ref1) 2012; 95
LD Shultz (ref24) 1995; 154
BL DeBuysscher (ref26) 2013; 7
B Rockx (ref30) 2009; 83
KP Dhondt (ref28) 2013; 207
CR Baskin (ref32) 2009; 106
O Escaffre (ref7) 2013; 7
MJ Cameron (ref33) 2008; 133
AR Medford (ref34) 2006; 61
VE Calderon (ref35) 2013; 8
NI Paton (ref3) 1999; 354
TC Savidge (ref19) 1995; 58
References_xml – volume: 10
  start-page: 2082
  year: 2004
  ident: ref4
  article-title: Nipah virus encephalitis reemergence, Bangladesh
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid1012.040701
– volume: 7
  start-page: e2024
  year: 2013
  ident: ref26
  article-title: Comparison of the pathogenicity of Nipah virus isolates from Bangladesh and Malaysia in the Syrian hamster
  publication-title: PLoS Negl Trop Dis
  doi: 10.1371/journal.pntd.0002024
– volume: 163
  start-page: 2127
  year: 2003
  ident: ref17
  article-title: A golden hamster model for human acute Nipah virus infection
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)63569-9
– volume: 8
  start-page: e63331
  year: 2013
  ident: ref35
  article-title: A humanized mouse model of tuberculosis
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0063331
– volume: 85
  start-page: 7658
  year: 2011
  ident: ref13
  article-title: Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection
  publication-title: J Virol
  doi: 10.1128/JVI.00473-11
– volume: 7
  start-page: e40308
  year: 2012
  ident: ref29
  article-title: A new model for Hendra virus encephalitis in the mouse
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0040308
– volume: 183
  start-page: 1258
  year: 2013
  ident: ref31
  article-title: Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2013.06.023
– volume: 5
  start-page: e1000642
  year: 2009
  ident: ref15
  article-title: A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1000642
– volume: 28
  start-page: 1248
  year: 2010
  ident: ref23
  article-title: Towards a knowledge-based Human Protein Atlas
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt1210-1248
– volume: 13
  start-page: 1031
  year: 2007
  ident: ref5
  article-title: Person-to-person transmission of Nipah virus in a Bangladeshi community
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid1307.061128
– volume: 61
  start-page: 621
  year: 2006
  ident: ref34
  article-title: Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?
  publication-title: Thorax
  doi: 10.1136/thx.2005.040204
– volume: 18
  start-page: 1983
  year: 2012
  ident: ref25
  article-title: Transmission Routes for Nipah Virus from Malaysia and Bangladesh
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid1812.120875
– volume: 161
  start-page: 2153
  year: 2002
  ident: ref8
  article-title: Nipah Virus Infection: Pathology and Pathogenesis of an Emerging Paramyxoviral Zoonosis
  publication-title: The American journal of pathology
  doi: 10.1016/S0002-9440(10)64493-8
– volume: 207
  start-page: 142
  year: 2013
  ident: ref28
  article-title: Type I interferon signaling protects mice from lethal henipavirus infection
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jis653
– volume: 46
  start-page: 977
  year: 2008
  ident: ref6
  article-title: Clinical presentation of nipah virus infection in Bangladesh
  publication-title: Clin Infect Dis
  doi: 10.1086/529147
– volume: 5
  start-page: 1176
  year: 2009
  ident: ref18
  article-title: Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model
  publication-title: Small
  doi: 10.1002/smll.200801572
– volume: 4
  start-page: 146ra107
  year: 2012
  ident: ref14
  article-title: A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3004241
– volume: 58
  start-page: 361
  year: 1995
  ident: ref19
  article-title: Human intestinal development in a severe-combined immunodeficient xenograft model
  publication-title: Differentiation
  doi: 10.1046/j.1432-0436.1995.5850361.x
– volume: 404
  start-page: 78
  year: 2010
  ident: ref9
  article-title: Characterization of the antiviral and inflammatory responses against Nipah virus in endothelial cells and neurons
  publication-title: Virology
  doi: 10.1016/j.virol.2010.05.005
– volume: 354
  start-page: 1257
  year: 1999
  ident: ref2
  article-title: Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia
  publication-title: Lancet
  doi: 10.1016/S0140-6736(99)04299-3
– volume: 93
  start-page: 3126
  year: 1996
  ident: ref21
  article-title: Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.93.7.3126
– volume: 95
  start-page: 135
  year: 2012
  ident: ref1
  article-title: Recent progress in henipavirus research: molecular biology, genetic diversity, animal models
  publication-title: Antiviral Res
  doi: 10.1016/j.antiviral.2012.05.008
– volume: 133
  start-page: 13
  year: 2008
  ident: ref33
  article-title: Human immunopathogenesis of severe acute respiratory syndrome (SARS)
  publication-title: Virus Res
  doi: 10.1016/j.virusres.2007.02.014
– volume: 125
  start-page: 413
  year: 2003
  ident: ref20
  article-title: Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(03)00902-8
– volume: 7
  start-page: 308
  year: 2013
  ident: ref7
  article-title: Pathogenesis of Hendra and Nipah virus infection in humans
  publication-title: J Infect Dev Ctries
  doi: 10.3855/jidc.3648
– volume: 107
  start-page: 1062
  year: 1995
  ident: ref36
  article-title: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time
  publication-title: Chest
  doi: 10.1378/chest.107.4.1062
– volume: 85
  start-page: 7863
  year: 2011
  ident: ref27
  article-title: Nipah virus uses leukocytes for efficient dissemination within a host
  publication-title: J Virol
  doi: 10.1128/JVI.00549-11
– volume: 5
  start-page: e10690
  year: 2010
  ident: ref16
  article-title: Development of an acute and highly pathogenic nonhuman primate model of nipah virus infection
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0010690
– volume: 154
  start-page: 180
  year: 1995
  ident: ref24
  article-title: Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice
  publication-title: J Immunol
  doi: 10.4049/jimmunol.154.1.180
– volume: 102
  start-page: 1014
  year: 2009
  ident: ref11
  article-title: Organ- and endotheliotropism of Nipah virus infections in vivo and in vitro
  publication-title: Thromb Haemost
  doi: 10.1160/TH09-05-0310
– volume: 5
  start-page: 142
  year: 2008
  ident: ref10
  article-title: Selective receptor expression restricts Nipah virus infection of endothelial cells
  publication-title: Virol J
  doi: 10.1186/1743-422X-5-142
– volume: 12
  start-page: 1720
  year: 2012
  ident: ref22
  article-title: Human cytomegalovirus infection leads to elevated levels of transplant arteriosclerosis in a humanized mouse aortic xenograft model
  publication-title: Am J Transplant
  doi: 10.1111/j.1600-6143.2012.04018.x
– volume: 106
  start-page: 3455
  year: 2009
  ident: ref32
  article-title: Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0813234106
– volume: 87
  start-page: 3284
  year: 2013
  ident: ref12
  article-title: Henipavirus Pathogenesis in Human Respiratory Epithelial Cells
  publication-title: J Virol
  doi: 10.1128/JVI.02576-12
– volume: 111
  start-page: 1306
  year: 1997
  ident: ref37
  article-title: Infections and the inflammatory response in acute respiratory distress syndrome
  publication-title: Chest
  doi: 10.1378/chest.111.5.1306
– volume: 83
  start-page: 7062
  year: 2009
  ident: ref30
  article-title: Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection
  publication-title: J Virol
  doi: 10.1128/JVI.00127-09
– volume: 354
  start-page: 1253
  year: 1999
  ident: ref3
  article-title: Outbreak of Nipah-virus infection among abattoir workers in Singapore
  publication-title: Lancet
  doi: 10.1016/S0140-6736(99)04379-2
SSID ssj0041316
Score 2.2934668
Snippet Nipah virus (NiV) is a member of the genus Henipavirus (family Paramyxoviridae) that causes severe and often lethal respiratory illness and encephalitis in...
Nipah virus (NiV) is a member of the genus Henipavirus (family Paramyxoviridae ) that causes severe and often lethal respiratory illness and encephalitis in...
  Nipah virus (NiV) is a member of the genus Henipavirus (family Paramyxoviridae) that causes severe and often lethal respiratory illness and encephalitis in...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e1004063
SubjectTerms Animals
Biology and Life Sciences
Chemokines
Cytokines
Cytokines - metabolism
Disease Models, Animal
Encephalitis
Endothelium
Epithelial Cells - metabolism
Epithelial Cells - pathology
Epithelial Cells - virology
Health aspects
Henipavirus Infections - metabolism
Henipavirus Infections - pathology
Heterografts
Histopathology
Host-parasite relationships
Host-Pathogen Interactions - physiology
Humans
Infections
Inflammation
Ligands
Lung Transplantation
Lungs
Medicine and Health Sciences
Mice
Mice, Inbred NOD
Microbiological research
Mortality
Nipah virus
Nipah Virus - physiology
Pathogenesis
R&D
Research & development
Respiratory Mucosa - metabolism
Respiratory Mucosa - pathology
Respiratory Mucosa - virology
Transplants & implants
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fi9QwEA6yIPgi_r6ep0QRfKp3Tdpki0-reJyC-6Ae3FtIk4m3sHTLdVf0v3cmTZerKPfiY9tJIZMvyQyZfB9jrzz40nphc1z8IacYPa-9anJfOfBNXTkfVRQ-L9XZefnporq4JvVFNWEDPfDguGOrbCGsBu1qV1pJEUNR-maulMVHHcm2cc8bk6lhDcaVOYqekihOrqVS6dKc1MVxGqM3XWeJPhpBrORkU4rc_fsVetatN_3fws8_qyivbUun99jdFE_yxdCP--wWtA_Y7UFh8tdD9nbBowofX-Ok5j-hpWqssOWU8AOPMjh8E_hy1dlL_mN1tev5WJ7VPmLnpx--vT_Lk15C7pSU27zwQZw0HrTVrqkqJ0FDIZyXTRFk0HUlLXjdCDf3toAAFCqIxjZCA1jASO8xm7WbFg4YD6HA1kqJUInSuXruSswErfb2ZB4cyIzJ0WHGJTJx0rRYm3hCpjGpGPpvyM0muTlj-b5VN5Bp3GD_jsZib0tU2PEFAsQkgJibAJKxlzSShsguWqqm-W53fW8-fl2ahVRaU8Yn_mn0ZWL0OhmFDXbW2XSDAV1GJFoTy6OJJU5ZN_l8QKga-9wbEqESNREZZezFiDRDragErgXEBNoUdCRaCp2xJwPy9o4RpcK0WeKP9QSTE89Nv7Sry0gmjvEo5ayH_8PVT9kdjCdTYdMRm22vdvAMY7Zt8zxOz98Dij79
  priority: 102
  providerName: Directory of Open Access Journals
Title A Human Lung Xenograft Mouse Model of Nipah Virus Infection
URI https://www.ncbi.nlm.nih.gov/pubmed/24699832
https://www.proquest.com/docview/1513049427
https://pubmed.ncbi.nlm.nih.gov/PMC3974875
https://doaj.org/article/a6a12a7e7c9c4a3083514db866a4a376
http://dx.doi.org/10.1371/journal.ppat.1004063
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9swEBdtymAvZd_11gVtDPbkUku2LmaMkY6WbtAwugXyJmR9tIFgZ3Ey2v9-OsU282jZHm2fbHS-k34nne5HyDtjTaoMU7Ef_G2MGD3OjShik2lrijzTJrAoXEzE-TT9OstmO6TlbG0UWN8Z2iGf1HS1OLr5efvJO_zHwNoASdvoaLlUWBDam6Xgu2TPz02ArnqRdvsKfsQOZKhIlhMDh7Q5THffW3qTVajp343cg-Wiqu-CpX9nV_4xXZ09IvsNzqTjrWE8Jju2fEIebJknb5-SD2Ma2Pnowjs7vbElZmm5NcWFAEsDPQ6tHJ3Ml-qa_pqvNjVt07bKZ2R6dvrj83nc8CjEWnC-jhPj2HFhLCjQRZZpbsEmTBteJI47yDOurIGC6ZFRiXUWIQQrVMHAWmU9AnxOBmVV2gNCnUt8ayGYy1iqdT7SqY8QFRh1PHLa8ojwVmFSN0XGketiIcPOGfhgY9t_iWqWjZojEnetltsiG_-QP8F_0cliiexwo1pdycbjpBIqYQos6FyniiPUTFJTjIRQ_hJERN7in5RYBKPELJsrtalr-eX7RI65AMBIkN0rdNkTet8Iucp3VqvmZINXGRbX6kke9iS9K-ve4wO0qrbPtURyKpZjgaOIvGktTWIrTI0rrbcJL5PgVmnKICIvtpbXKYalwofT3L8YejbZ01z_STm_DkXGPU7FWPblf3z3FXnoYWSTz3RIBuvVxr72UG1dDMkuzGBI9k5OJ98uh2HBYxg88jdPD0IY
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+human+lung+xenograft+mouse+model+of+Nipah+virus+infection&rft.jtitle=PLoS+pathogens&rft.au=Valbuena%2C+Gustavo&rft.au=Halliday%2C+Hailey&rft.au=Borisevich%2C+Viktoriya&rft.au=Goez%2C+Yenny&rft.date=2014-04-01&rft.issn=1553-7374&rft.eissn=1553-7374&rft.volume=10&rft.issue=4&rft.spage=e1004063&rft_id=info:doi/10.1371%2Fjournal.ppat.1004063&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1553-7374&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1553-7374&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1553-7374&client=summon